earnings
confidence high
sentiment positive
materiality 0.75
ResMed Q1 FY2026 revenue +9% to $1.34B; non-GAAP EPS $2.55 (+16%); dividend $0.60
RESMED INC
2026-Q1 EPS reported
$2.37
revenue$1,335,582,000
- Revenue $1,335.6M (+9% YoY, +8% constant currency); diluted EPS $2.37, non-GAAP EPS $2.55 (+16%).
- Gross margin up 290 bps to 61.5%; non-GAAP gross margin 62.0% (up 280 bps).
- Operating cash flow $457M; income from operations +15% (+19% non-GAAP).
- Board declared quarterly dividend of $0.60 per share, payable Dec 18 to holders of record Nov 13.